Sort by
Refine Your Search
-
the dual task of supporting all students in the University, graduate and undergraduate, and managing multiple campus departments and services that serve the entire campus community. CSL's programs and
-
the Institute's strategic initiatives and priorities. The Senior Director will develop an outreach program that engages leaders and supporters around the world who can benefit from the research discoveries and
-
of supporting all students in the University, graduate and undergraduate, and managing multiple campus departments and services that serve the entire campus community. CSL's programs and services focus
-
partnerships with campus units and external language centers. Plans, advertises, and executes a variety of CLC events in collaboration with program staff. Designs and distributes promotional materials (flyers
-
visionary leadership for the development, review, distribution, and alignment of high-impact donor-facing materials. The Senior Director is responsible for developing and driving strategies for gift proposals
-
efforts. Partners with TMW Center staff members and other stakeholders in pursuing new participants to ensure study has adequate amount of participants. Obtains and maintains consents for program
-
, higher level data products, and distribution to the cancer research community, working across multiple teams to build and automate frameworks such as anomaly detection, reporting, and alerting to ensure
-
the Woman’s Hospital, as well as partner with Cardiology to develop distributed ECMO capabilities (e.g., cath lab cannulation, ICU readiness at multiple sites). Lead recruitment, retention, and advancement
-
. Responsibilities Provides materials for protocol development to study chairs and assistance in implementing protocol development policies and procedures. Formats, proofreads, and edits protocols. Distributes
-
clinical research. Our research program is one of the largest gynecologic oncology programs in the Midwest, with an average of 18-22 therapeutic phase phase I-III trials open at all-times. We need a clinical